Kyorin Pharmaceutical Co., Ltd. (KYRNF) - Analysis

opens in 4h 24m

005930 189,600.00 13.40%
0700 495.60 2.40%
2330 1,850.00 5.11%
ASML 1,157.60 3.43%
AZN 14,948.91 1.76%
ETH/USD 2,138.85 1.59%
EUR/USD 1.16 0.36%
MC 471.95 1.91%
NESN 78.27 -0.19%
USD/JPY 158.51 -0.13%
XPT/USD 1,003.20 0.33%

005930 189,600.00 13.40%
0700 495.60 2.40%
2330 1,850.00 5.11%
ASML 1,157.60 3.43%
AZN 14,948.91 1.76%
ETH/USD 2,138.85 1.59%
EUR/USD 1.16 0.36%
MC 471.95 1.91%
NESN 78.27 -0.19%
USD/JPY 158.51 -0.13%
XPT/USD 1,003.20 0.33%

005930 189,600.00 13.40%
0700 495.60 2.40%
2330 1,850.00 5.11%
ASML 1,157.60 3.43%
AZN 14,948.91 1.76%
ETH/USD 2,138.85 1.59%
EUR/USD 1.16 0.36%
MC 471.95 1.91%
NESN 78.27 -0.19%
USD/JPY 158.51 -0.13%
XPT/USD 1,003.20 0.33%

005930 189,600.00 13.40%
0700 495.60 2.40%
2330 1,850.00 5.11%
ASML 1,157.60 3.43%
AZN 14,948.91 1.76%
ETH/USD 2,138.85 1.59%
EUR/USD 1.16 0.36%
MC 471.95 1.91%
NESN 78.27 -0.19%
USD/JPY 158.51 -0.13%
XPT/USD 1,003.20 0.33%

10.31000 USD

0.16

1.53%

Last update Mar 7, 3:00 PM EST

Market closed

Day range

10.31000

10.31000

10.31000

Previous close

10.47000

Open

10.31000

Access this stock data via API

Kyorin Pharmaceutical Co., Ltd.

10.31

0.16

1.53%

Analysis

Revenue estimate	Next year (Mar 2027)
Number of Analysts	1
Avg. estimate	125.58B
Low estimate	125.58B
High estimate	125.58B
Last year sales	126.10B
Sales growth	0

Access /revenue_estimate data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

EPS revisions	Next year (Mar 2027)
Up last 7 days	0
Up last 30 days	0
Down last 7 days	0
Down last 30 days	0

Access /eps_revisions data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.